Aurobindo Pharma, Cadila recall medication from US market


New Delhi: Aurobindo Pharma and Cadila Healthcare have recalled over 25,500 bottles of two totally different medication within the US attributable to presence of international tablets and failed dissolution specs.

Aurobindo Pharma USA Inc is recalling 23,016 bottles of Pantoprazole Sodium delayed-release tablets USP, 40 mg because the agency “obtained a market grievance stating the presence of 1 international pill (Montelukast Sodium Chewable tab 4mg) within the product bottle of Pantoprazole,” the most recent enforcement report on the USFDA web site mentioned.

Pantoprazole Sodium delayed-release tablets are used for therapy of erosive irritation of the esophagus attributable to acid reflux disease. The product was manufactured at Aurobindo Pharma’s Mahaboob Nagar plant.

In response to the report this can be a Class II recall by Aurobindo Pharma. Amerisource Well being Companies is recalling 2,626 bottles of Bupropion Hydrochloride extended-release tablets USP (XL), 300 mg manufactured by Ahmedabad based mostly Cadila Healthcare.

The recall is because of “failed dissolution specs—specification outcome for dissolution was recognized throughout 3 month stability testing,” the enforcement report by the US Meals and Drug Administration (USFDA) mentioned.

Cadila Healthcare’s voluntary ongoing Class III recall is nationwide and in Puerto Rico, USFDA mentioned. Bupropion Hydrochloride prolonged launch tablets are used for therapy of main depressive dysfunction.

The Class II recall is initiated in a scenario wherein use of or publicity to a violative product might trigger short-term or medically reversible hostile well being penalties or the place the likelihood of significant hostile well being penalties is distant.

A Class III recall is initiated in a “scenario wherein use of or publicity to a violative product will not be prone to trigger hostile well being penalties.”

Catch all of the Company information and Updates on Dwell Mint.
Obtain The Mint Information App to get Every day Market Updates & Dwell Enterprise Information.

Much less

Subscribe to Mint Newsletters

* Enter a sound electronic mail

* Thanks for subscribing to our publication.


Supply hyperlink